Kazia Therapeutics (KZIA) Invested Capital (2017 - 2025)

Kazia Therapeutics' Invested Capital history spans 6 years, with the latest figure at $2.8 million for Q2 2025.

  • For Q2 2025, Invested Capital fell 11.86% year-over-year to $2.8 million; the TTM value through Jun 2025 reached $2.8 million, down 11.86%, while the annual FY2025 figure was $2.8 million, 11.86% down from the prior year.
  • Invested Capital reached $2.8 million in Q2 2025 per KZIA's latest filing, down from $3.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $13.8 million in Q2 2023 to a low of $2.8 million in Q2 2025.
  • Average Invested Capital over 4 years is $7.9 million, with a median of $7.4 million recorded in 2022.
  • Peak YoY movement for Invested Capital: grew 17.25% in 2023, then plummeted 77.36% in 2024.
  • A 4-year view of Invested Capital shows it stood at $11.8 million in 2022, then increased by 17.25% to $13.8 million in 2023, then tumbled by 77.36% to $3.1 million in 2024, then fell by 11.86% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Invested Capital are $2.8 million (Q2 2025), $3.1 million (Q2 2024), and $13.8 million (Q2 2023).